Eosinophils and their interactions with respiratory virus pathogens

被引：36

作者：

Rosenberg, Helene F. ^{[1
]}

Dyer, Kimberly D. ^{[1
]}

Domachowske, Joseph B. ^{[2
]}

机构：

[1] NIAID, Eosinophil Biol Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA

[2] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA

来源：

IMMUNOLOGIC RESEARCH | 2009年 / 43卷 / 1-3期

关键词：

Eosinophils; Inflammation; Virus; Ribonuclease; Cytokine; SYNCYTIAL VIRUS; PNEUMOVIRUS INFECTION; PNEUMONIA VIRUS; HOST-DEFENSE; RIBONUCLEASE GENES; ASTHMA; MICE; EVOLUTION; FAMILY; BRONCHIOLITIS;

D O I：

10.1007/s12026-008-8058-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Eosinophils are implicated in the pathophysiology of respiratory virus infection, most typically in negative roles, such as promoting wheezing and bronchoconstriction in conjunction with virus-induced exacerbations of reactive airways disease and in association with aberrant hypersensitivity responses to viral vaccines. However, experiments carried out in vitro and in vivo suggest positive roles for eosinophils, as they have been shown to reduce virus infectivity in tissue culture and promote clearance of the human pathogen, respiratory syncytial virus in a mouse challenge model. The related natural rodent pathogen, pneumonia virus of mice (PVM), is highly virulent in mice, and is not readily cleared by eosinophils in vivo. Interestingly, PVM replicates in eosinophils and promotes cytokine release. The molecular basis of virus infection in eosinophils and its relationship to disease outcome is currently under study.

引用

页码：128 / 137

页数：10

共 38 条

[1] Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection:: Eosinophils mediate airway hyperresponsiveness, M2 muscarinic receptor dysfunction, and antiviral effects[J]. Adamko, DJ;Yost, BL;Gleich, GJ;Fryer, AD;Jacoby, DB. JOURNAL OF EXPERIMENTAL MEDICINE, 1999(10)
[2] Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis[J]. Bonville, CA;Rosenberg, HF;Domachowske, JB. ANTIVIRAL RESEARCH, 2006(02)
[3] Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo[J]. Bonville, CA;Lau, VK;DeLeon, JM;Gao, JL;Easton, AJ;Rosenberg, HF;Domachowske, JB. JOURNAL OF VIROLOGY, 2004(15)
[4] Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents[J]. Bonville, CA;Easton, AJ;Rosenberg, HF;Domachowske, JB. JOURNAL OF VIROLOGY, 2003(02)
[5] Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis[J]. Bonville, Cynthia A.;Bennett, Nicholas J.;Koehnlein, Melissa;Haines, Deborah M.;Ellis, John A.;DelVeechio, Alfred M.;Rosenberg, Helene F.;Domachowske, Joseph B. VIROLOGY, 2006(01)
[6] Borchers MT, 2002, J LEUKOCYTE BIOL, V71, P1033
[7] Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease[J]. Castilow, Elaine M.;Olson, Matthew R.;Varga, Steven M. IMMUNOLOGIC RESEARCH, 2007(1-3)
[8] Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus[J]. Domachowske, JB;Dyer, KD;Bonville, CA;Rosenberg, HF. JOURNAL OF INFECTIOUS DISEASES, 1998(06)
[9] Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow[J]. Dyer, Kimberly D.;Moser, Jennifer M.;Czapiga, Meggan;Siegel, Steven J.;Percopo, Caroline M.;Rosenberg, Helene F. JOURNAL OF IMMUNOLOGY, 2008(06)
[10] Easton A. J., 2006, PERSPECTIVES MED VIR, P299

← 1 2 3 4 →